John G. Lemkey, Officer, Chief Financial Officer, Chief Operating Officer, Chief Executive Officer at Odonate Therapeutics, Inc. (ODT), bought 57,846 shares at $14.85 ($848K) on 2018-12-17, disclosed to the SEC on 2018-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.08 | 10,000 | $151K | 17.8% |
| 2 | $14.51 | 9,550 | $139K | 16.3% |
| 3 | $14.51 | 9,550 | $139K | 16.3% |
| 4 | $14.85 | 8,296 | $123K | 14.5% |
| 5 | $14.85 | 8,296 | $123K | 14.5% |
| 6 | $15.20 | 450 |
| $7K |
| 0.8% |
| 7 | $14.13 | 10,000 | $141K | 16.7% |
| 8 | $15.18 | 1,704 | $26K | 3.0% |
| Total | $14.67 avg | 57,846 | $848K | 100% |
| Filing → |
| ODT | BUY | 2019-03-11 | $4.7M | — | Filing → |
| ODT | BUY | 2018-12-26 | $756K | — | Filing → |
| ODT | BUY | 2018-10-25 | $919K | — | Filing → |